1. The Company VOC Diagnostics AB
Our vision
To reduce mortality globally, increase quality of life and reduce patient care costs by enabling a paradigm shift in early diagnosis of cancer.
Value proposition
Provide an easy and reliable analysis method that can detect cancer at an early stage with high accuracy

2. The Product (OC detect) An electronic nose with inspiration from man’s best friend
Ability to detect VOCs specific for ovarian cancer from blood
100% sensitivity and 97.5% specificity in double-blind tests
OC Detect
Patented electronic nose for detection and diagnosis of ovarian cancer from blood
Gas sensors to detect volatile organic compounds (VOCs) emitted by cancer tumors
Advanced SW algorithm and statistical analysis
92% sensitivity and 93% specificity showed in a published clinical study on 165 bloodsamples.(Horvath et al, J Cancer Sci Ther, Dec 2018)

3. Business case: Targeting a potential multi-billion market
Market for ovarian cancer diagnostics in €
Europe
United states
Diagnosis
Test volume
(nr of tests)
(nr of tests)
Price (€/test) 50
Market value
75 MIO
50 MIO
Early detection on symptoms 25
150 MIO
100 MIO
Screening 10
380 MIO
240 MIO
Note: Prices are specified for specific total volumes for given scenarios, not dependent on uses at particular time. I.e. the price is assumed to be the same at given time regardless of used for diagnosis or screening